✦ LIBER ✦

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

✍ Scribed by Hummel, Trent R.; Wagner, Lars; Ahern, Charlotte; Fouladi, Maryam; Reid, Joel M.; McGovern, Renee M.; Ames, Matthew M.; Gilbertson, Richard J.; Horton, Terzah; Ingle, Ashish M.; Weigel, Brenda; Blaney, Susan M.

Book ID: 120602030
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 133 KB
Volume: 60
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.24541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of vorinostat and bortez

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

✍ Jodi A. Muscal; Patrick A. Thompson; Terzah M. Horton; Ashish M. Ingle; Charlott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Phase 1 study of oxaliplatin and irinote

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors : A Children's Oncology Group Study

✍ Lisa M. McGregor; Sheri L. Spunt; Wayne L. Furman; Clinton F. Stewart; Paula Sch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Phase II study of oxaliplatin in childre

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors : A pediatric brain tumor consortium study

✍ Maryam Fouladi; Susan M. Blaney; Tina Young Poussaint; Burgess B. Freeman III; R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Safety and activity of crizotinib for pa

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

✍ Mossé, Yael P; Lim, Megan S; Voss, Stephan D; Wilner, Keith; Ruffner, Katherine; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 116 KB

Phase III study of PSC-833 (valspodar) i

Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95) : A trial of the Eastern Cooperative Oncology Group

✍ William R. Friedenberg; Montserrat Rue; Emily A. Blood; William S. Dalton; Chaim 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views